Partners of TI Pharma include Small & Medium sized Enterprises (SME's), academia and knowledge institutes, large industry, health foundations and patient organizations, regulatory authorities and governments.

SME's:
3D-PharmXchange, Aeon Astron Europe, Agamyxis, Agendia, Arcarios, Batavia Bioservices, Bio Detection Systems, BioMarin, BioNovion, Bioceros, CardioGenx, Centre for Human Drug Research (CHDR), DC Prime, Feyecon, Glycostem Therapeutics, HQ Medical, InteRNA Technologies, IOTA Pharmaceuticals, IQ Corporation/IQ Therapeutics, ISA Therapeutics, Isconova, Lead Pharma, LifeAssay Diagnostics, Madam Therapeutics, Magistro, Mercachem, Mymetics, Mucosis, Netherlands Translational Research Centre (NTRC), OctoPlus, PamGene, Pansynt, Pepscan Presto, Pepscan Therapeutics, Percuros, Pivot Park Screening Centre, Prosensa Therapeutics, Proxy Laboratories, Syncom, Synvolux Therapeutics, TropIQ, UbiQ, Vaxinostics, Vertex Pharmaceuticals Incorporated, ViroClinics Biosciences

Academia:
AMC, Erasmus Medical Centre, Erasmus University Rotterdam, Leiden University, Leiden University Medical Center (LUMC), Maastricht University, Maastricht University Medical Center (MUMC), Radboud University Nijmegen, Radboud University Nijmegen Medical Centre (RUNMC), University Medical Center Groningen (UMCG), University Medical Center Utrecht (UMCU), University of Amsterdam (UvA), University of Bern, University of Groningen (RUG), Utrecht University, VU University Amsterdam, VU University Medical Center (VUmc), Wageningen University & Research Centre


Knowledge Institutes:
Drugs for Neglected Diseases initiative (DNDi), Foundation for Innovative New Diagnostics (FIND),Hubrecht Institute, Jan van Es Institute, Netherlands Cancer Institute (NKI), The Netherlands Institute for Neuroscience (NIN), Netherlands Institute for Health Services Research (NIVEL), Netherlands Translational Research Center (NTRC), Royal Tropical Institute (KIT), TNO Quality of Life, Het Wetenschappelijk Instituut Nederlandse Apothekers (WINAp)

Large Industry:
Abbott, Actelion, Amgen, Astellas Pharma Europe, AstraZeneca, Centocor R&D , Danone, DSM Biomedical, Eli Lilly Nederland, Galapagos, GE Healthcare, Genzyme Europe, GlaxoSmithKline, Merck Sharp & Dohme, MSD Oss, Johnson & Johnson Belgium, Lundbeck, Notox, Nycomed, Pfizer, PRA International, QPS Netherlands, Sanaria, Sanofi-Aventis, Shire Human Genetic Therapies, Vertex Pharmaceuticals

Health Foundations:

Patient Organizations:
VKS (Vereniging Volwassenen, Kinderen en Stofwisselingsziekten), VSN (Vereniging Spierziekten Nederland), FSIGN (Fabry Support & Informatie Groep Nederland)

Regulatory Authorities:
Medicines Evaluation Board (CBG-MEB) 

Government:
The Netherlands Vaccine Institute (NVI-RIVM), ZonMW, Life Sciences & Health (LSH) Health Care Insurance Companies: Health Care Insurance Board (CVZ)

Other:
Nefarma, Foundation for Innovative New Diagnostics (FIND)

“Running public-private partnerships is a profession by itself. TI Pharma is an excellent example of how you can do this in an effective way.”

Hugo Hurts
Director/Secretary of the Medicines Evaluation Board

Hugo Hurts
Director/Secretary of the Medicines Evaluation Board

Share this page: